Knabbe C - Search Results

1

Creatinine measurements by the Jaffé method in different peritoneal dialysis fluids exhibit wide variation.

Alscher DM, Muerdter TE, Knabbe C, Kuhlmann U, Dippon J, Hoffmann JE, Lage C. Alscher DM, et al. Among authors: knabbe c. Perit Dial Int. 2006 Mar-Apr;26(2):280-3. Perit Dial Int. 2006. PMID: 16623438 No abstract available.

2

Moulds in containers with biological wastes as a possible source of peritonitis in two patients on peritoneal dialysis.

Alscher DM, Pfinder-Nohe E, Rumpf D, Pauli-Magnus C, Knabbe C, Kuhlmann U, Mettang T. Alscher DM, et al. Among authors: knabbe c. Perit Dial Int. 1998 Nov-Dec;18(6):643-6. Perit Dial Int. 1998. PMID: 9932665 No abstract available.

3

Containers for waste causing peritonitis in CAPD patients.

Alscher DM, Pfinder-Nohe E, Rumpf D, Pauli-Magnus C, Knabbe C, Kuhlmann U, Mettang T, Krankenhaus RB. Alscher DM, et al. Among authors: knabbe c. EDTNA ERCA J. 2001 Jul-Sep;27(3):140-2, 146. doi: 10.1111/j.1755-6686.2001.tb00162.x. EDTNA ERCA J. 2001. PMID: 11868996

4

Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients.

Buck MB, Fritz P, Dippon J, Zugmaier G, Knabbe C. Buck MB, et al. Among authors: knabbe c. Clin Cancer Res. 2004 Jan 15;10(2):491-8. doi: 10.1158/1078-0432.ccr-0320-03. Clin Cancer Res. 2004. PMID: 14760070

5

Smad4-expression is decreased in breast cancer tissues: a retrospective study.

Stuelten CH, Buck MB, Dippon J, Roberts AB, Fritz P, Knabbe C. Stuelten CH, et al. Among authors: knabbe c. BMC Cancer. 2006 Jan 26;6:25. doi: 10.1186/1471-2407-6-25. BMC Cancer. 2006. PMID: 16438724 Free PMC article.

6

Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.

Buck MB, Pfizenmaier K, Knabbe C. Buck MB, et al. Among authors: knabbe c. Mol Endocrinol. 2004 Jul;18(7):1643-57. doi: 10.1210/me.2003-0278. Epub 2004 Mar 31. Mol Endocrinol. 2004. PMID: 15056732

7

A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.

Beisner J, Buck MB, Fritz P, Dippon J, Schwab M, Brauch H, Zugmaier G, Pfizenmaier K, Knabbe C. Beisner J, et al. Among authors: knabbe c. Cancer Res. 2006 Aug 1;66(15):7554-61. doi: 10.1158/0008-5472.CAN-06-0634. Cancer Res. 2006. PMID: 16885354

8

TGF-beta signaling in breast cancer.

Buck MB, Knabbe C. Buck MB, et al. Among authors: knabbe c. Ann N Y Acad Sci. 2006 Nov;1089:119-26. doi: 10.1196/annals.1386.024. Ann N Y Acad Sci. 2006. PMID: 17261761 Review.

9

TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells.

Buck MB, Coller JK, Mürdter TE, Eichelbaum M, Knabbe C. Buck MB, et al. Among authors: knabbe c. Breast Cancer Res Treat. 2008 Jan;107(1):15-24. doi: 10.1007/s10549-007-9526-7. Epub 2007 Feb 15. Breast Cancer Res Treat. 2008. PMID: 18043895

10

Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.

Stope MB, Popp SL, Knabbe C, Buck MB. Stope MB, et al. Among authors: knabbe c. Breast Cancer Res Treat. 2010 Apr;120(2):357-67. doi: 10.1007/s10549-009-0393-2. Epub 2009 Apr 16. Breast Cancer Res Treat. 2010. PMID: 19370415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters